Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase

Journal of Clinical Oncology

Volumn 29, Issue 17, 2011, Pages

  Vigil, Carlos E ^a   Wang, Sa A ^a   Cortes, Jorge E ^a   Bueso Ramos, Carlos ^a   Verstovsek, Srdan ^a   Shinder, Roman ^a   Chen, Su S ^a   Katz, Ruth L ^a   Khanna, Abha ^a   Esmaeli, Bita ^a   Manning, John T ^a   You, M James ^a   Miranda, Roberto N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; CD45 ANTIGEN; CD59 ANTIGEN; CD63 ANTIGEN; CD69 ANTIGEN; CYTARABINE; DASATINIB; HEMOGLOBIN; INTERLEUKIN 2 RECEPTOR ALPHA; LACTATE DEHYDROGENASE; STEM CELL FACTOR RECEPTOR; TRYPTASE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; BONE BIOPSY; BONE MARROW BIOPSY; CASE REPORT; CELL INFILTRATION; CELL POPULATION; CHRONIC MYELOID LEUKEMIA; ENZYME BLOOD LEVEL; EOSINOPHIL; FEMUR FRACTURE; FEMUR HEAD; FIBROSIS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HEMATOPOIESIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LEG PAIN; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; MASTOCYTOMA; MASTOCYTOSIS; ORBIT DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; THROMBOCYTE COUNT; TREATMENT RESPONSE; TUMOR NECROSIS; UNSPECIFIED SIDE EFFECT; WALKING DIFFICULTY;

BLAST CRISIS; BONE MARROW; FEMUR; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; ORBITAL NEOPLASMS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; THIAZOLES;

EID: 79959253026     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.34.1610     Document Type: Article

References (20)

1. Korbling M, Katz RL, Khanna A, et al: Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 346:738-746, 2002 (Pubitemid 34983994)
2. Luthra R, Sanchez-Vega B, Medeiros LJ: TaqMan RT-PCR assay coupled with capillary electrophoresis for quantification and identification of bcr-abl transcript type. Mod Pathol 17:96-103, 2004 (Pubitemid 41656458)
3. Cross NC, Feng L, Chase A, et al: Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82:1929-1936, 1993
4. Lin P, Luthra R, Nussenzveig RH, et al: JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome. Hum Pathol 41:758-762, 2010
5. Vardiman J, Melo JV, Baccarani M, et al: Chronic myelogenous leukaemia, BCR-ABL1 positive, in Swerdlow S, Campo, E, Harris, NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4). Lyon, France, International Agency for Research and Cancer, 2008, pp 32-37
6. Morel F, Herry A, Le Bris MJ, et al: Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocations in chronic myelocytic leukemia. Cancer Genet Cytogenet 147:115-120, 2003 (Pubitemid 37414869)
7. Sperr WR, Drach J, Hauswirth AW, et al: Myelomastocytic leukemia: Evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation. Clin Cancer Res 11:6787-6792, 2005 (Pubitemid 41428732)
8. Horny H, Metcalfe DD, Bennett JM, et al: Mastocytosis, in Swerdlow S, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4). Lyon, France, International Agency for Research on Cancer, 2008, pp 54-63
9. Valent P, Samorapoompichit P, Sperr WR, et al: Myelomastocytic leukemia: Myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells. Hematol J 3:90-94, 2002 (Pubitemid 34555535)
10. Soler J, O'Brien M, de Castro JT, et al: Blast crisis of chronic granulocytic leukemia with mast cell and basophilic precursors. Am J Clin Pathol 83:254-259, 1985 (Pubitemid 15128860)
11. Valent P, Spanblöchl E, Bankl HC, et al: Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis. Blood 84:4322-4332, 1994 (Pubitemid 24371939)
12. Palandri F, Castagnetti F, Testoni N, et al: Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: Outcome of the patients alive after a 6-year follow-up. Haematologica 93:1792-1796, 2008
13. Rosenthal S, Canellos GP, DeVita VT Jr, et al: Characteristics of blast crisis in chronic granulocytic leukemia. Blood 49:705-714, 1977 (Pubitemid 8093467)
14. Maloisel F, Favre G, Mahmal L, et al: Isolated lytic bone lesion as extramedullary disease in chronic myelogenous leukemia: A report of three new cases. Eur J Intern Med 16:288-290, 2005 (Pubitemid 41111512)
15. Yu HH, Lu MY, Lin DT, et al: Pathological fracture as a manifestation of extramedullary blastic crisis in chronic myelogenous leukemia: Report of one case. Acta Paediatr Taiwan 47:150-154, 2006
16. Kantarjian HM, Cortes J, O'Brien S, et al: Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase. Blood 99:3547-3553, 2002 (Pubitemid 34534521)
17. Jabbour E, Fullmer A, Cortés JE, et al: Clinical algorithms for the treatment of patients with chronic myeloid leukemia: The 2010 perspective. Clin Lymphoma Myeloma Leuk 10:S6-S13, 2010 (suppl 1)
18. Sacchi S, Kantarjian HM, O'Brien S, et al: Chronic myelogenous leukemia in nonlymphoid blastic phase: Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients. Cancer 86:2632-2641, 1999 (Pubitemid 30004667)
19. Cairoli R, Grillo G, Beghini A, et al: Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis. Hematol J 5:273-275, 2004 (Pubitemid 38931334)
20. Agis H, Sotlar K, Valent P, et al: Ph-chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis. Leuk Res 29:1227-1232, 2005 (Pubitemid 41169242)